Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego F Calvisi

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
The American Journal of Pathology|February 1, 2014
Hydrodynamic transfection for generation of novel mouse models for liver cancer researchXin Chen, Diego F Calvisi
Translational Gastroenterology and Hepatology|July 8, 2020
Hepatoblastoma: current knowledge and promises from preclinical studiesDiego F Calvisi, Antonio Solinas
Hepatology (Baltimore, Md.)|July 22, 2014
New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatmentSilvia Vilarinho, Diego F Calvisi
Gastroenterology|June 4, 2013
Molecular diagnostic algorithms in hepatocellular carcinoma: dead-end street or light at the end of the tunnel?Peter Schirmacher, Diego F Calvisi
World Journal of Gastroenterology|April 3, 2015
Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomasAntonio Solinas, Diego F Calvisi
Hepatology (Baltimore, Md.)|August 13, 2016
The dark side of the moon: AKT as a tumor suppressor in the liver?Xin Chen, Diego F Calvisi
Toxicologic Pathology|April 5, 2005
Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancerDiego F Calvisi, Snorri S Thorgeirsson
Seminars in Liver Disease|March 25, 2021
Organoids for the Study of Liver CancerHaichuan Wang, Diego F Calvisi, Xin Chen
Expert Opinion on Therapeutic Targets|September 3, 2021
Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristicsHaichuan Wang, Xin Chen, Diego F Calvisi
Virchows Archiv : an International Journal of Pathology|June 28, 2020
Nuclear ErbB2 expression in hepatocytes in liver diseasePaula Döring, Diego F Calvisi, Frank Dombrowski
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
The American Journal of Pathology|February 1, 2014
Hydrodynamic transfection for generation of novel mouse models for liver cancer researchXin Chen, Diego F Calvisi
Translational Gastroenterology and Hepatology|July 8, 2020
Hepatoblastoma: current knowledge and promises from preclinical studiesDiego F Calvisi, Antonio Solinas
Hepatology (Baltimore, Md.)|July 22, 2014
New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatmentSilvia Vilarinho, Diego F Calvisi
Gastroenterology|June 4, 2013
Molecular diagnostic algorithms in hepatocellular carcinoma: dead-end street or light at the end of the tunnel?Peter Schirmacher, Diego F Calvisi
World Journal of Gastroenterology|April 3, 2015
Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomasAntonio Solinas, Diego F Calvisi
Hepatology (Baltimore, Md.)|August 13, 2016
The dark side of the moon: AKT as a tumor suppressor in the liver?Xin Chen, Diego F Calvisi
Toxicologic Pathology|April 5, 2005
Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancerDiego F Calvisi, Snorri S Thorgeirsson
Seminars in Liver Disease|March 25, 2021
Organoids for the Study of Liver CancerHaichuan Wang, Diego F Calvisi, Xin Chen
Expert Opinion on Therapeutic Targets|September 3, 2021
Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristicsHaichuan Wang, Xin Chen, Diego F Calvisi
Virchows Archiv : an International Journal of Pathology|June 28, 2020
Nuclear ErbB2 expression in hepatocytes in liver diseasePaula Döring, Diego F Calvisi, Frank Dombrowski
Pageof 24